Abstract
Background: Hypoglycemia remains to stand for a usual metabolic problem dealing with the neonatal populace. Both healthy and ill-appearing neonates could be impacted by hypoglycemia throughout the very first days of life. Severe neonatal hypoglycemia (HG) leads to neurologic damage, mental retardation, epilepsy, personality disorders, impaired cardiac performance and muscle weakness.
Objective: The goal of this review is to highlight the background of the inborn errors of metabolism that present with neonatal hypoglycemia to understand more and discuss management of neonatal hypoglycemia.
Methodology: We conducted a search using electronic databases; MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials (CENTRAL), up to November, 2018.
Conclusion: Neonatal HG is important factor in the general neonatal death. HG could additionally create serious invalidity. Treatment of the hypoglycemic infant may begin while investigations continue.